E-viri
PDF
Recenzirano
Odprti dostop
-
Tardif, Jean-Claude; Kouz, Simon; Waters, David D; Bertrand, Olivier F; Diaz, Rafael; Maggioni, Aldo P; Pinto, Fausto J; Ibrahim, Reda; Gamra, Habib; Kiwan, Ghassan S; Berry, Colin; López-Sendón, José; Ostadal, Petr; Koenig, Wolfgang; Angoulvant, Denis; Grégoire, Jean C; Lavoie, Marc-André; Dubé, Marie-Pierre; Rhainds, David; Provencher, Mylène; Blondeau, Lucie; Orfanos, Andreas; L’Allier, Philippe L; Guertin, Marie-Claude; Roubille, François
The New England journal of medicine, 12/2019, Letnik: 381, Številka: 26Journal Article
Inflammation appears to play a role in atherosclerosis, raising the possibility that treatments that reduce inflammation could prevent cardiovascular events. In a randomized, placebo-controlled trial involving 4745 patients with recent myocardial infarction, low-dose colchicine (0.5 mg once daily) prevented ischemic cardiovascular events.
